An anti-androgen resistance-related gene signature acts as a prognostic marker and increases enzalutamide efficacy via PLK1 inhibition in prostate cancer
Saved in:
| Main Authors: | Yongzheng Han, Wenlong Xie, Guangzhen Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Journal of Translational Medicine |
| Online Access: | https://doi.org/10.1186/s12967-025-06731-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An anti-androgen resistance-related gene signature acts as a prognostic marker and increases enzalutamide efficacy via PLK1 inhibition in prostate cancer
by: Ruilin Zhuang, et al.
Published: (2025-04-01) -
Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer
by: Shankha S. Chatterjee, et al.
Published: (2024-11-01) -
Targeting RPS6KC1 to overcome enzalutamide resistance in prostate cancer
by: Fu-Hao Ji, et al.
Published: (2025-08-01) -
Cost-effectiveness of talazoparib plus enzalutamide as first-line therapy in metastatic castration-resistant prostate cancer
by: Jiaming Zhu, et al.
Published: (2025-08-01) -
Letter to the editor: Wnt5a augments intracellular free cholesterol levels and promotes castration resistance in prostate cancer
by: Yongzheng Han, et al.
Published: (2025-08-01)